Skip to content

Author

Chang-Chun Zeng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Recent Advances in Tumor-Infiltrating Lymphocyte Therapy for Melanoma

Overall, TIL therapy constitutes a rapidly evolving and clinically potent treatment modality for melanoma and covers recent advances for improving therapeutic outcomes, including safety optimization, product optimization, next-generation engineered TILs, and predictive biomarkers.

H. Zeng, Wu-Xuan Mei, Chang-Chun Zeng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.